Diadema Partners’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Diadema Partners's DFTX Position: Q3 2026 in Review
Diadema Partners sold out of Definium Therapeutics (DFTX) in Q3 2026, closing a stake of 15,451 shares — an estimated $727K sold.
Diadema Partners first reported a position in DFTX in Q4 2024 and held it in 4 quarters. The position peaked at $1.25M in Q3 2025. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Diadema Partners reported no remaining Definium Therapeutics position as of Q3 2026 after selling out during the quarter.
- Diadema Partners sold 15,451 Definium Therapeutics shares in Q3 2026, an estimated $727K.
- Diadema Partners first reported a position in Definium Therapeutics in Q4 2024 and held it in 4 quarters.
- Diadema Partners's Definium Therapeutics position peaked at $1.25M in Q3 2025.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Diadema Partners's 13F filing for Q3 2026, filed 16 Nov 2026.